13.67 USD
↗ 0.23 (1.71%)AT CLOSE (11:59 AM EDT)
Atrium Therapeutics, Inc. Common Stock
RNANASDAQ • USD
13.67
↗ 0.01 (0.04%)
POST MARKET (AS OF 05:47 PM EDT)
Post Market
AS OF 05:47 PM EDT
13.67
↗ 0.01 (0.04%)
Market: OPEN
Open?$13.44
High?$13.92
Low?$13.44
Prev. Close?$13.44
Volume?172.9K
Avg. Volume?N/A
VWAP?$13.67
Bid / Ask
Bid?$13.66 × 100
Ask?$13.69 × 200
Spread?$0.03
Midpoint?$13.68
Valuation & Ratios
Market Cap?208.5M
Shares Out?17.1M
Float?16.2M
Float %?94.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.